WHAT WE DO
Frontier Diagnostics is looking at redefining how researchers study cancer biology. With our advanced liquid biopsy platform, we are developing tools to capture and analyse circulating tumour cells (CTCs), opening new opportunities to investigate tumour dynamics at stages that may precede conventional methods of detection. Our research solutions will empower scientists to explore the potential for earlier insights and more individualised approaches in oncology.
WHY IT MATTERS
Personalised CARE
Unlocking the potential to explore how therapies could be matched to individual patient profiles—even before treatment begins. Research into circulating tumour cells (CTCs) is opening new avenues to investigate tumour biology and therapeutic response.
Fast, Non-Invasive Tests – coming soon
No biopsies. Just a simple blood draw.
Continuous Monitoring
Explore the potential to study tumour dynamics in real time and provide researchers with new insights that may inform future approaches in oncology. The tests, which will soon be available as Research Use Only, however registration as IVD is in progress.
SERVICES
IN-HOUSE TESTING
Clinics can send us the samples, and we will return the results within 5 working days.
ON-SITE TESTING
Larger hospitals will be able to use our Quantum FluoScope device for same day in-house diagnostics.
